Skip to main content
Erschienen in: Acta Diabetologica 1/2009

01.03.2009 | Original Article

Ophthalmoplegia in diabetes mellitus: a retrospective study

verfasst von: Domenico Greco, Francesco Gambina, Filippo Maggio

Erschienen in: Acta Diabetologica | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Ophthalmoplegia, despite being a rare entity in diabetes mellitus, is associated with great anxiety for the patients and often appears to be a serious problem from a diagnostic and therapeutic point of view. There have been few studies primarily concerned with the relative frequencies and clinical characteristics of oculomotor neuropathies in diabetic subjects. Those published have emanated largely from neurological and/or ophthalmological referral centres rather than metabolic departments. Objective of this study was to determine the incidence, the clinical characteristics and risk factors for developing ophthalmoplegia among persons with diabetes mellitus. We have performed a retrospective study of all diabetic patients with ophthalmoplegia who were seen in the Metabolic Division at “S. Biagio” Hospital, Marsala, over the 10 year period from 1998 to 2007. A detailed history and blood laboratory profile were obtained for each patient. During the period of the survey a total of 6,765 diabetic subjects were hospitalised and ophthalmoplegia was identified in 27 patients (0.40%). Isolated III nerve palsies accounted for the majority of patients (59.3%), with VI nerve palsies (29.6%) occurring more frequently than multiple palsies (11.1%). These patients had a marked comorbidity and were found to have a poorly controlled diabetes. The patients with VI nerve palsies showed a tendency toward a higher coexistence of diabetic retinopathy and cardiovascular risk factors than those with III cranial nerve palsies. Ophthalmoplegia is a serious and not common problem among patients with diabetes mellitus; the oculomotor nerve was most frequently affected in our case-report. The fact that the coexistence of diabetic complications and cardiovascular risk factors was slightly higher in patients with VI nerve palsy is compatible with the hypothesis that this ischemic event might be more closely related to diabetes and metabolic syndrome in its pathogenesis.
Literatur
1.
Zurück zum Zitat Boulton AJM, Arezzo JC, Lamik RA, Sosenko JM (2004) Diabetic somatic neuropathies. Diabetes Care 27:1458–1486PubMedCrossRef Boulton AJM, Arezzo JC, Lamik RA, Sosenko JM (2004) Diabetic somatic neuropathies. Diabetes Care 27:1458–1486PubMedCrossRef
2.
Zurück zum Zitat Watanabe K, Hagura R, Akanuma Y, Takasu T, Kajinuma H, Kuzuya N, Irie M (1990) Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 10:19–27PubMedCrossRef Watanabe K, Hagura R, Akanuma Y, Takasu T, Kajinuma H, Kuzuya N, Irie M (1990) Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 10:19–27PubMedCrossRef
3.
Zurück zum Zitat Richards BW, Jones FR, Younge BR (1992) Causes and prognosis in 4278 cases of paralysis of the oculomotor, trochlear and abducens cranial nerves. Am J Ophthalmol 113:489–496PubMed Richards BW, Jones FR, Younge BR (1992) Causes and prognosis in 4278 cases of paralysis of the oculomotor, trochlear and abducens cranial nerves. Am J Ophthalmol 113:489–496PubMed
4.
Zurück zum Zitat Rush JA, Younge BR (1981) Paralysis of cranial nerves III, IV, and VI: cause and prognosis in 1000 cases. Arch Ophthalmol 99:76–79PubMed Rush JA, Younge BR (1981) Paralysis of cranial nerves III, IV, and VI: cause and prognosis in 1000 cases. Arch Ophthalmol 99:76–79PubMed
5.
Zurück zum Zitat Jacobson DM, McCanna TD, Layde PM (1994) Risk factors for ischemic ocular motor nerve palsies. Arch Ophthalmol 112:961–966PubMed Jacobson DM, McCanna TD, Layde PM (1994) Risk factors for ischemic ocular motor nerve palsies. Arch Ophthalmol 112:961–966PubMed
6.
Zurück zum Zitat Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486–2497CrossRef Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486–2497CrossRef
7.
Zurück zum Zitat Lazzaroni F, Laffi GL, Galuppi V, Scorolli L (1993) Paralysis of oculomotor nerves in diabetes mellitus. A retrospective study of 44 cases. Rev Neurol Paris 149:571–573PubMed Lazzaroni F, Laffi GL, Galuppi V, Scorolli L (1993) Paralysis of oculomotor nerves in diabetes mellitus. A retrospective study of 44 cases. Rev Neurol Paris 149:571–573PubMed
8.
Zurück zum Zitat Tiffin PA, MacEwen CJ, Craig EA, Clayton G (1996) Acquired palsy of the oculomotor, trochlear and abducens nerves. Eye 10:377–384PubMed Tiffin PA, MacEwen CJ, Craig EA, Clayton G (1996) Acquired palsy of the oculomotor, trochlear and abducens nerves. Eye 10:377–384PubMed
9.
Zurück zum Zitat Berlit P (1991) Isolated and combined pareses of cranial nerves III, IV, and VI. A retrospective study of 412 patients. J Neurol Sci 103:10–15PubMedCrossRef Berlit P (1991) Isolated and combined pareses of cranial nerves III, IV, and VI. A retrospective study of 412 patients. J Neurol Sci 103:10–15PubMedCrossRef
10.
Zurück zum Zitat Batocchi AP, Evoli A, Majolini L, Lo Monaco M, Padua L, Ricci E, Dickman A, Tonali P (1997) Ocular palsies in the absence of other neurological or ocular symptoms: analysis of 105 cases. J Neurol 244:639–645PubMedCrossRef Batocchi AP, Evoli A, Majolini L, Lo Monaco M, Padua L, Ricci E, Dickman A, Tonali P (1997) Ocular palsies in the absence of other neurological or ocular symptoms: analysis of 105 cases. J Neurol 244:639–645PubMedCrossRef
11.
Zurück zum Zitat Dominguez D, Gomensoro J, Temesio P, Rodriguez-Barrios R (1974) Diabetic ophthalmoplegia. Acta Diabet Lat 11:198–205CrossRef Dominguez D, Gomensoro J, Temesio P, Rodriguez-Barrios R (1974) Diabetic ophthalmoplegia. Acta Diabet Lat 11:198–205CrossRef
12.
Zurück zum Zitat Naghmi R, Subuhi R (1990) Diabetic oculomotor mononeuropathy: involvement of pupillomotor fibres with slow resolution. Horm Metab Res 22:38–40PubMedCrossRef Naghmi R, Subuhi R (1990) Diabetic oculomotor mononeuropathy: involvement of pupillomotor fibres with slow resolution. Horm Metab Res 22:38–40PubMedCrossRef
13.
Zurück zum Zitat Goldstein JE, Cogan DG (1960) Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol 64:592–598PubMed Goldstein JE, Cogan DG (1960) Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol 64:592–598PubMed
14.
Zurück zum Zitat Fraser DM, Campbell IW, Ewing DJ, Clarke BF (1979) Mononeuropathy in diabetes mellitus. Diabetes 28:96–101PubMedCrossRef Fraser DM, Campbell IW, Ewing DJ, Clarke BF (1979) Mononeuropathy in diabetes mellitus. Diabetes 28:96–101PubMedCrossRef
15.
Zurück zum Zitat Tankova T, Cherninkova S, Koev D (2005) Treatment for diabetic mononeuropathy with α-lipoic acid. Int J Clin Pract 59:645–650PubMedCrossRef Tankova T, Cherninkova S, Koev D (2005) Treatment for diabetic mononeuropathy with α-lipoic acid. Int J Clin Pract 59:645–650PubMedCrossRef
16.
Zurück zum Zitat Smith BE, Dyck PJ (1992) Subclinical histopathological changes in the oculomotor nerve in diabetes mellitus. Ann Neurol 32:376–385PubMedCrossRef Smith BE, Dyck PJ (1992) Subclinical histopathological changes in the oculomotor nerve in diabetes mellitus. Ann Neurol 32:376–385PubMedCrossRef
17.
Zurück zum Zitat Asbury AK, Aldredge H, Hershberg R, Fisher CM (1970) Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 93:955–966CrossRef Asbury AK, Aldredge H, Hershberg R, Fisher CM (1970) Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 93:955–966CrossRef
18.
Zurück zum Zitat Patel SV, Holmes JM, Hodge DO, Burke JP (2005) Diabetes and hypertension in isolated sixth nerve palsy. Ophthalmology 112:760–763PubMedCrossRef Patel SV, Holmes JM, Hodge DO, Burke JP (2005) Diabetes and hypertension in isolated sixth nerve palsy. Ophthalmology 112:760–763PubMedCrossRef
19.
Zurück zum Zitat Johnson LN, Stetson SW, Krohel GB, Cipollo CL, Madsen RW (2000) Aspirin use and the prevention of acute ischemic cranial nerve palsy. Am J Ophthalmol 129:367–371PubMedCrossRef Johnson LN, Stetson SW, Krohel GB, Cipollo CL, Madsen RW (2000) Aspirin use and the prevention of acute ischemic cranial nerve palsy. Am J Ophthalmol 129:367–371PubMedCrossRef
Metadaten
Titel
Ophthalmoplegia in diabetes mellitus: a retrospective study
verfasst von
Domenico Greco
Francesco Gambina
Filippo Maggio
Publikationsdatum
01.03.2009
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 1/2009
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-008-0053-8

Weitere Artikel der Ausgabe 1/2009

Acta Diabetologica 1/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.